Table 2.
Primary analysis CT-positive hDAI | |||||||
---|---|---|---|---|---|---|---|
Crude | Adjusted | ||||||
OR (95% CI) | p | C-statistic | OR (95% CI) | p | C-statistic | H-L p | |
Discharge survival (n=361) | 2.4 (1.3–4.2) | 0.004 | 0.562 | 2.0 (0.99–3.9)a | 0.06 | 0.761 | 0.061 |
Favorable 3-month outcome (n=276) | 2.1 (1.1–4.1) | 0.03 | 0.563 | 1.7 (0.8–3.9)a | 0.19 | 0.789 | 0.961 |
Favorable 12-month outcome (n=255) | 2.6 (1.4–5.1) | 0.005 | 0.578 | 1.6 (0.7–3.4) b | 0.27 | 0.758 | 0.586 |
Secondary analysis Predominant hDAI | |||||||
Crude | Adjusted | ||||||
OR (95% CI) | p | C-statistic | OR (95% CI) | p | C-statistic | H-L p | |
Discharge survival (n=327) | 28.7 (3.9–211.9) | 0.001 | 0.586 | 24.7 (3.2–192.6)c | 0.002 | 0.773 | 0.71 |
Favorable 3-month outcome (n=248) | 4.2 (1.8–10.2) | 0.001 | 0.575 | 2.3 (0.9–6.4)b | 0.1 | 0.761 | 0.313 |
Favorable 12-month outcome (n=230) | 9.9 (3.4–28.5) | <.001 | 0.602 | 4.7 (1.5–15.2)c | 0.01 | 0.769 | 0.336 |
Associated hDAI | |||||||
Crude | Adjusted | ||||||
OR (95% CI) | p | C-statistic | OR (95% CI) | p | C-statistic | H-L p | |
Discharge survival (n=325) | 0.8 (0.4–1.7) | 0.58 | 0.509 | 1.12 (0.4–2.8)d | 0.96 | 0.772 | 0.072 |
Favorable 3-month outcome (n=253) | 1.1 (0.4–2.8) | 0.90 | 0.503 | 1.3 (0.4–4.1)d | 0.69 | 0.801 | 0.857 |
Favorable 12-month outcome (n=235) | 0.8 (0.3–2.3) | 0.71 | 0.509 | 0.5 (0.1–2.1)e | 0.25 | 0.851 | 0.836 |
Multivariable logistic regression models were adjusted for:
age, ISS, hypotension, Marshall CT classification;
age, ISS, and Marshall CT classification;
age, ISS, Marshall CT classification, and presence of contusion;
age, ISS, hypotension, and pupillary reactivity;
age, ISS, hypotension, pupillary reactivity and trauma cause. hDAI denotes hemorrhagic DAI; ISS, Injury Severity Score; H-L, Hosmer-Lemeshow; OR, odds ratio; CI, confidence interval. CT-hDAI negative patients served as reference group. A Hosmer-Lemeshow p-value of >0.05 indicates good model calibration.